Celladon Corporation Receives Patent from United States Patent and Trademark ... Sacramento Bee 8221738 with claims that cover the administration of MYDICAR, Celladon's first in class drug under clinical evaluation for advanced heart failure. The patent, titled "Methods of enhanced uptake of viral vectors in the myocardium" carries a patent term ... |
